Andy C Dean

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences and Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, CA 90095 1759, USA
    Neuropsychopharmacology 38:259-74. 2013
  2. doi request reprint Examination of the impact of ethnicity on the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) Fake Bad Scale
    Andy C Dean
    Department of Neuropsychology, Harbor UCLA Medical Center, Torrance, CA 90509, USA
    Clin Neuropsychol 22:1054-60. 2008
  3. pmc Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute, 760 Westwood Plaza, Box 951759, Los Angeles, CA 90095, USA
    Drug Alcohol Depend 105:48-55. 2009
  4. doi request reprint Educational attainment is not a good proxy for cognitive function in methamphetamine dependence
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences and Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, CA 90095 1759, USA
    Drug Alcohol Depend 123:249-54. 2012
  5. pmc Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, California 90095 1759, USA
    J Stud Alcohol Drugs 72:943-53. 2011
  6. doi request reprint Dementia and effort test performance
    Andy C Dean
    Harbor UCLA Medical Center, Neuropsychology Department, Torrance, CA 90509, USA
    Clin Neuropsychol 23:133-52. 2009
  7. pmc Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence
    Sara L Simon
    Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, California 90095 1759, USA
    J Stud Alcohol Drugs 71:335-44. 2010
  8. pmc Is all risk bad? Young adult cigarette smokers fail to take adaptive risk in a laboratory decision-making test
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences and Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    Psychopharmacology (Berl) 215:801-11. 2011
  9. ncbi request reprint The relationship of IQ to effort test performance
    Andy C Dean
    Harbor UCLA Medical Center, Torrance, CA, USA
    Clin Neuropsychol 22:705-22. 2008

Detail Information

Publications9

  1. pmc An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences and Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, CA 90095 1759, USA
    Neuropsychopharmacology 38:259-74. 2013
    ..When averaged across individuals, this decline is likely to be mild in early-to-middle adulthood. However, moderator variables are likely to contribute to the presence and/or severity of cognitive decline exhibited by a given individual...
  2. doi request reprint Examination of the impact of ethnicity on the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) Fake Bad Scale
    Andy C Dean
    Department of Neuropsychology, Harbor UCLA Medical Center, Torrance, CA 90509, USA
    Clin Neuropsychol 22:1054-60. 2008
    ..We failed to find significant ethnic differences in mean FBS performance or in cut-off specificity rates. We did find evidence of a gender effect, supporting continued use of gender-specific FBS cutoffs...
  3. pmc Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute, 760 Westwood Plaza, Box 951759, Los Angeles, CA 90095, USA
    Drug Alcohol Depend 105:48-55. 2009
    ..On the basis of these findings, we recommend that research groups seeking to identify new predictors of treatment outcome compare the predictors to methamphetamine usage variables to assure that unique predictive power is attained...
  4. doi request reprint Educational attainment is not a good proxy for cognitive function in methamphetamine dependence
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences and Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, CA 90095 1759, USA
    Drug Alcohol Depend 123:249-54. 2012
    ....
  5. pmc Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, California 90095 1759, USA
    J Stud Alcohol Drugs 72:943-53. 2011
    ..We thus sought to evaluate the effects of modafinil on the cognitive performance of methamphetamine-dependent and healthy individuals...
  6. doi request reprint Dementia and effort test performance
    Andy C Dean
    Harbor UCLA Medical Center, Neuropsychology Department, Torrance, CA 90509, USA
    Clin Neuropsychol 23:133-52. 2009
    ..Analyses of test specificity as a function of Mini Mental Status Examination (MMSE) score and specific dementia diagnosis are provided, as well as adjustments to cut-offs to maintain specificity where feasible...
  7. pmc Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence
    Sara L Simon
    Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, California 90095 1759, USA
    J Stud Alcohol Drugs 71:335-44. 2010
    ..The purpose of this work was to assess neuropsychological functioning of individuals in early abstinence from methamphetamine dependence and to test for cognitive change over the first month of abstinence...
  8. pmc Is all risk bad? Young adult cigarette smokers fail to take adaptive risk in a laboratory decision-making test
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences and Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    Psychopharmacology (Berl) 215:801-11. 2011
    ..Initial studies have suggested that smokers display greater risk-taking on this task than nonsmokers, but these studies did not account for drug abuse and psychiatric comorbidities, which are commonplace among smokers...
  9. ncbi request reprint The relationship of IQ to effort test performance
    Andy C Dean
    Harbor UCLA Medical Center, Torrance, CA, USA
    Clin Neuropsychol 22:705-22. 2008
    ..All patients with IQ < 70 failed at least one effort test. Cutoffs for the Warrington Recognition Memory Test (Words) and Finger Tapping maintained the highest specificities in low IQ samples...